| Literature DB >> 29125861 |
Janine Gronewold1, Christian Dahlmann2, Marcus Jäger3, Dirk M Hermann1.
Abstract
BACKGROUND: As a consequence of demographic changes, hospitals are confronted with increasing numbers of elderly patients, who are at high risk of adverse events during hospitalization. Geriatric risk screening followed by comprehensive geriatric assessment (CGA) and treatment has been requested by geriatric societies and task forces to identify patients at risk. Since empirical evidence on factors predisposing to adverse hospital events is scarce, we now prospectively evaluated implications of geriatric risk screening followed by CGA in a university hospital department of orthopedics and trauma surgery.Entities:
Mesh:
Year: 2017 PMID: 29125861 PMCID: PMC5695284 DOI: 10.1371/journal.pone.0187801
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Characteristics of the total study cohort also split by ISAR score and CGA results.
| Total | ISAR- | ISAR+/CGA normal | ISAR+/CGA abnormal | p-value ISAR+/CGA normal vs ISAR- | p-value ISAR+/CGA abnormal vs ISAR- | p-value ISAR+/CGA abnormal vs ISAR+/CGA normal | |
|---|---|---|---|---|---|---|---|
| Age (years) | 82.5±5.5 | 79.3±3.8 | 80.8±4.7 | 83.4±5.5 | 0.185 | ||
| Sex (male) | 95(24.9) | 20(37.0) | 12(23.1) | 57(23.0) | 0.138 | 0.999 | |
| Anemia | 18(4.7) | 0 | 0 | 18(7.3) | 0.999 | 0.051 | 0.051 |
| Chronic kidney disease | 55(14.4) | 6(11.1) | 5(9.6) | 43(17.3) | 0.999 | 0.315 | 0.213 |
| Heart failure | 45(11.8) | 1(1.9) | 4(7.7) | 39(15.7) | 0.205 | 0.190 | |
| Coronary heart disease | 64(16.8) | 3(5.6) | 10(19.2) | 48(19.4) | 0.999 | ||
| Atrial fibrillation | 70(18.1) | 4(7.4) | 8(15.4) | 56(22.6) | 0.236 | 0.272 | |
| Other cardiac arrhythmias | 32(8.4) | 2(3.7) | 4(7.7) | 26(10.5) | 0.437 | 0.190 | 0.623 |
| Valve insufficiency | 34(8.9) | 3(5.6) | 3(5.8) | 26(10.5) | 0.999 | 0.322 | 0.325 |
| Chronic obstructive pulmonary disease | 24(6.3) | 0 | 4(7.7) | 17(6.9) | 0.057 | 0.092 | 0.999 |
| Peripheral artery disease | 11(2.9) | 2(3.7) | 1(1.9) | 6(2.4) | 0.999 | 0.634 | 0.999 |
| Arterial hypertension | 260(68.2) | 40(74.1) | 34(65.4) | 169(68.1) | 0.402 | 0.514 | 0.745 |
| Diabetes | 79(20.7) | 6(11.1) | 9(17.3) | 60(24.2) | 0.416 | 0.365 | |
| Hyperlipoproteinemia | 23(6.0) | 3(5.6) | 2(3.8) | 17(6.9) | 0.999 | 0.782 | 0.545 |
| Nicotine abuse | 5(1.3) | 0 | 1(1.9) | 4(1.6) | 0.495 | 0.603 | 0.999 |
| Obesity | 12(3.1) | 0 | 2(3.8) | 8(3.2) | 0.243 | 0.359 | 0.686 |
| History of myocardial infarction | 25(6.6) | 1(1.9) | 6(11.5) | 17(6.9) | 0.254 | ||
| History of pulmonary embolism | 10(2.6) | 0 | 3(5.8) | 7(2.8) | 0.118 | 0.361 | 0.386 |
| History of stroke | 27(7.1) | 2(3.7) | 3(5.8) | 21(8.5) | 0.678 | 0.279 | 0.778 |
| History of thrombosis | 14(3.7) | 2(3.7) | 3(5.8) | 9(3.6) | 0.678 | 0.999 | 0.443 |
| Hyperthyroidism | 5(1.3) | 2(3.7) | 1(1.9) | 2(0.8) | 0.999 | 0.144 | 0.436 |
| Hypothyroidism | 45(11.8) | 5(9.3) | 5(9.6) | 32(12.9) | 0.999 | 0.510 | 0.646 |
| Dementia | 69(18.1) | 1(1.9) | 5(9.6) | 53(21.4) | 0.113 | 0.054 | |
| Alcohol abuse | 12(2.1) | 0 | 0 | 10(4.0) | 0.999 | 0.219 | 0.220 |
| Depression | 23(6.0) | 3(5.6) | 2(3.8) | 12(4.8) | 0.999 | 0.999 | 0.999 |
| Anxiety disorder | 5(1.3) | 0 | 1(1.9) | 4(1.6) | 0.495 | 0.603 | 0.999 |
| Parkinson’s disease | 14(3.7) | 3(5.6) | 1(1.9) | 9(3.6) | 0.618 | 0.449 | 0.999 |
| Polyneuropathy | 13(3.4) | 3(5.6) | 2(3.8) | 6(2.4) | 0.999 | 0.369 | 0.631 |
| Cancer | 53(13.9) | 8(14.8) | 4(7.7) | 38(15.3) | 0.359 | 0.999 | 0.189 |
| Cataract | 15(3.9) | 1(1.9) | 2(3.8) | 12(4.8) | 0.618 | 0.477 | 0.999 |
| Presbyacusia | 8(2.1) | 2(3.7) | 0 | 6(2.4) | 0.495 | 0.634 | 0.595 |
| Anal incontinence | 2(0.5) | 0 | 0 | 1(0.4) | 0.999 | 0.999 | 0.999 |
| Urinary incontinence | 11(2.9) | 1(1.9) | 0 | 7(2.8) | 0.999 | 0.999 | 0.609 |
| Decubitus | 7(1.8) | 0 | 1(1.9) | 6(2.4) | 0.495 | 0.379 | 0.999 |
CGA, comprehensive geriatric assessment; ISAR, Identification of Seniors at Risk. ISAR+, positive ISAR screening (score ≥2); ISAR-, negative ISAR screening (score <2). In 327 ISAR+ patients, 300 CGAs were performed (27 missing due to transfer, discharge, foreign-language or incompliance of patients). For definition of abnormal CGA see section ‘Comprehensive geriatric assessment’ in ‘Materials and Methods‘.
Medical main diagnosis of the total study cohort also split by ISAR score and CGA results.
| Diagnosis | Total | ISAR- | ISAR+/CGA normal | ISAR+/CGA abnormal |
|---|---|---|---|---|
| Acetabulum fracture | 4(1.0) | 0 | 0 | 4(1.6) |
| Femoral neck fracture | 41(10.8) | 2(3.7) | 0 | 38(15.3) |
| Femoral shaft facture | 37(9.7) | 4(7.4) | 0 | 29(11.7) |
| Patella fracture | 2(0.5) | 2(3.7) | 0 | 0 |
| Tibial or fibular fracture | 13(3.4) | 0 | 0 | 10(4.0) |
| Ankle fracture | 9(2.4) | 3(5.6) | 0 | 6(2.4) |
| Tarsal bone fracture | 2(0.5) | 0 | 0 | 2(0.8) |
| Metatarsal fracture | 1(0.3) | 0 | 0 | 1(0.4) |
| Clavicular fracture | 1(0.3) | 0 | 0 | 0 |
| Humerus fracture | 27(7.1) | 2(3.7) | 8(15.4) | 15(6.0) |
| Radius fracture | 25(6.6) | 3(5.6) | 4(7.7) | 17(6.9) |
| Ulnar fracture | 14(3.7) | 3(5.6) | 5(9.6) | 5(2.0) |
| Metacarpal fracture | 1(0.3) | 0 | 0 | 0 |
| Finger fracture | 2(0.5) | 1(1.9) | 0 | 1(0.4) |
| Spinal fracture | 33(8.7) | 5(9.3) | 2(3.8) | 22(8.9) |
| Rib fracture | 5(1.3) | 1(1.9) | 1(1.9) | 3(1.2) |
| Pelvic fracture | 1(0.3) | 0 | 0 | 1(0.4) |
| Basal skull fracture | 4(1.0) | 1(1.9) | 0 | 2(0.8) |
| Pathological fracture | 6(1.6) | 1(1.9) | 1(1.9) | 4(1.6) |
| Bone tumor | 10(2.6) | 2(3.7) | 0 | 8(3.2) |
| Joint dislocation | 3(0.8) | 0 | 1(1.9) | 1(0.4) |
| Mechanical complication or loosening of joint replacement | 5(1.3) | 1(1.9) | 0 | 4(1.6) |
| Mechanical complication osteosynthesis | 7(1.8) | 1(1.9) | 1(1.9) | 5(2.0) |
| Infection joint replacement | 8(2.1) | 0 | 1(1.9) | 7(2.8) |
| Septic arthritis | 1(0.3) | 1(1.9) | 0 | 0 |
| Articular effusion | 2(0.5) | 0 | 0 | 2(0.8) |
| Meniscus damage | 1(0.3) | 1(1.9) | 0 | 0 |
| Open wound | 4(1.0) | 0 | 0 | 4(1.6) |
| Ulcus cruris | 2(0.5) | 1(1.9) | 0 | 1(0.4) |
| Postoperative hematoma | 1(0.3) | 0 | 0 | 1(0.4) |
| Bursitis | 1(0.3) | 0 | 0 | 1(0.4) |
| Discitis | 6(1.6) | 0 | 1(1.9) | 5(2.0) |
| Erysipela | 2(0.5) | 0 | 0 | 2(0.8) |
| Abscess | 1(0.3) | 0 | 0 | 1(0.4) |
| Pseudarthrosis | 4(1.0) | 1(1.9) | 0 | 3(1.2) |
| Osteomyelitis | 2(0.5) | 1(1.9) | 0 | 1(0.4) |
| Phlegmone | 1(0.3) | 0 | 0 | 1(0.4) |
| Omarthrosis | 1(0.3) | 0 | 0 | 1(0.4) |
| Gonarthrosis | 2(0.5) | 0 | 1(1.9) | 1(0.4) |
| Coxarthrosis | 5(1.3) | 2(3.7) | 0 | 3(1.2) |
| Spinal stenosis | 11(2.9) | 4(7.4) | 2(3.8) | 4(1.6) |
| Spinal pain | 23(6.0) | 5(9.3) | 11(21.2) | 7(2.8) |
| Intervertebral disc displacement | 4(1.0) | 1(1.9) | 2(3.8) | 1(0.4) |
| Cerebral concussion | 20(5.2) | 3(5.6) | 9(17.3) | 6(2.4) |
| Subdural hematoma | 2(0.5) | 1(1.9) | 0 | 1(0.4) |
| Subarachnoid hemorrhage | 3(0.8) | 0 | 0 | 2(0.8) |
| Early trauma complication | 3(0.8) | 1(1.9) | 1(1.9) | 1(0.4) |
| Hemopneumothorax | 1(0.3) | 0 | 0 | 1(0.4) |
| Bruise | 16(4.2) | 0 | 1(1.9) | 12(4.8) |
| Muscle disorders | 1(0.3) | 0 | 0 | 1(0.4) |
Abbreviations as in Table 1.
Fig 1Prevalence of ISAR items (A) for the total cohort, (B) for ISAR+ and (C) for ISAR-. Abbreviations as in Table 1.
Fig 2Association of ISAR and CGA results with (A) Length of hospital stay in days, (B) Length of hospital stay in categories, (C) Nursing hours per day and (D) total hours of physiotherapy. *p<0.001 compared with ISAR-, †p<0.001 compared with ISAR+/CGA normal. Abbreviations as in Table 1.
Fig 3Association of ISAR and CGA results with type of discharge.
*p<0.05 compared with ISAR-, †p<0.05 compared with ISAR+/CGA normal. Abbreviations as in Table 1.
Predictors of total length of hospital stay in days for patients with ISAR+ receiving CGA (n = 300).
| Unadjusted | Model 1 | Model 2 | Model 3 | |||||||||
| β or B | 95% CI | p-value | β or B | 95% CI | p-value | β or B | 95% CI | p-value | β or B | 95% CI | p-value | |
| Age | -0.21 | -0.32 to -0.10 | <0.001 | -0.20 | -0.31 to -0.09 | 0.001 | -0.25 | -0.36 to -0.14 | <0.001 | -0.25 | -0.35 to -0.14 | <0.001 |
| Sex (male vs female) | 5.17 | 2.51 to 7.82 | <0.001 | 4.61 | 1.95 to 7.28 | 0.001 | 3.99 | 1.42 to 6.57 | 0.002 | 4.08 | 1.55 to 6.60 | 0.002 |
| Number of admission diagnoses | 0.38 | 0.27 to 0.49 | <0.001 | |||||||||
| ISAR score | 0.02 | -0.09 to 0.14 | 0.708 | 0.10 | -0.02 to 0.21 | 0.094 | ||||||
| Activities of daily living impairment (yes vs no) | 7.01 | 3.93 to 10.08 | <0.001 | 8.27 | 5.33 to 11.21 | <0.001 | ||||||
| Mobility impairment | 5.35 | 2.29 to 8.41 | 0.001 | 6.61 | 3.62 to 9.60 | <0.001 | ||||||
| Cognition impairment | 0.28 | -2.27 to 2.83 | 0.827 | 0.33 | -2.09 to 2.76 | 0.788 | 0.33 | -2.01 to 2.71 | 0.784 | |||
| Signs of depression | 4.53 | 1.30 to 7.76 | 0.006 | 3.94 | 0.86 to 7.03 | 0.012 | 4.49 | 1.47 to 7.51 | 0.004 | |||
| Model 4 | Model 5 | Model 6 | ||||||||||
| β or B | 95% CI | p-value | β or B | 95% CI | p-value | β or B | 95% CI | p-value | ||||
| Age | -0.25 | -0.36 to -0.14 | <0.001 | -0.26 | -0.37 to -0.15 | <0.001 | -0.24 | -0.35 to -0.14 | <0.001 | |||
| Sex (male vs female) | 4.05 | 1.52 to 6.58 | 0.002 | 4.13 | 1.58 to 6.67 | 0.002 | 2.56 | 0.54 to 5.06 | 0.045 | |||
| Number of admission diagnoses | 0.28 | 0.18 to 0.39 | <0.001 | |||||||||
| ISAR score | 0.03 | -0.08 to 0.15 | 0.550 | 0.02 | -0.09 to 0.13 | 0.698 | ||||||
| Activities of daily living impairment (yes vs no) | 7.05 | 3.00 to 11.10 | 0.001 | 7.01 | 2.95 to 11.06 | 0.001 | 5.72 | 1.82 to 9.63 | 0.004 | |||
| Mobility impairment | 1.77 | -2.27 to 5.81 | 0.389 | 1.68 | -2.38 to 5.74 | 0.417 | 1.18 | -2.71 to 5.06 | 0.552 | |||
| Cognition impairment | 0.30 | -2.01 to 2.68 | 0.806 | 0.20 | -2.21 to 2.60 | 0.873 | -0.20 | -2.51 to 2.10 | 0.862 | |||
| Signs of depression | 4.35 | 1.31 to 7.39 | 0.005 | 4.25 | 1.19 to 7.31 | 0.007 | 3.72 | 0.79 to 6.65 | 0.013 | |||
β, standardized regression coefficient; B, unstandardized regression coefficient; CI, confidence interval; other abbreviations as in Table 1.
Predictors of nursing hours per day for patients with ISAR+ receiving CGA (n = 300).
| Unadjusted | Model 1 | Model 2 | Model 3 | |||||||||
| β or B | 95% CI | p-value | β or B | 95% CI | p-value | β or B | 95% CI | p-value | β or B | 95% CI | p-value | |
| Age | 0.14 | 0.02 to 0.25 | 0.018 | 0.08 | -0.04 to 0.19 | 0.183 | 0.06 | -0.06 to 0.17 | 0.322 | 0.06 | -0.05 to 0.17 | 0.286 |
| Sex (male vs female) | -0.06 | -0.38 to 0.26 | 0.714 | 0.07 | -0.24 to 0.39 | 0.647 | 0.01 | -0.01 to 0.04 | 0.968 | 0.02 | -0.29 to 0.32 | 0.920 |
| Number of admission diagnoses | 0.34 | 0.23 to 0.44 | <0.001 | |||||||||
| ISAR score | 0.27 | 0.16 to 0.38 | <0.001 | 0.26 | 0.14 to 0.37 | <0.001 | ||||||
| Activities of daily living impairment (yes vs no) | 1.01 | 0.66 to 1.36 | <0.001 | 0.94 | 0.59 to 1.30 | <0.001 | ||||||
| Mobility impairment | 0.85 | 0.48 to 1.18 | <0.001 | 0.75 | 0.39 to 1.11 | <0.001 | ||||||
| Cognition impairment | 0.52 | 0.23 to 0.81 | 0.001 | 0.45 | 0.15 to 0.74 | 0.003 | 0.45 | 0.16 to 0.74 | 0.002 | |||
| Signs of depression | 0.12 | -0.26 to 0.51 | 0.523 | -0.06 | -0.43 to 0.32 | 0.768 | 0.01 | -0.36 to 0.37 | 0.974 | |||
| Model 4 | Model 5 | Model 6 | ||||||||||
| β or B | 95% CI | p-value | β or B | 95% CI | p-value | β or B | 95% CI | p-value | ||||
| Age | 0.05 | -0.06 to 0.17 | 0.346 | 0.02 | -0.09 to 0.13 | 0.745 | 0.04 | -0.07 to 0.15 | 0.508 | |||
| Sex (male vs female) | 0.01 | -0.29 to 0.32 | 0.935 | 0.07 | -0.24 to 0.37 | 0.666 | -0.12 | -0.42 to 0.18 | 0.431 | |||
| Number of admission diagnoses | 0.29 | 0.18 to 0.39 | <0.001 | |||||||||
| ISAR score | 0.20 | 0.09 to 0.32 | <0.001 | 0.19 | 0.08 to 0.30 | 0.001 | ||||||
| Activities of daily living impairment (yes vs no) | 0.81 | 0.32 to 1.30 | 0.001 | 0.78 | 0.30 to 1.26 | 0.002 | 0.63 | 0.16 to 1.09 | 0.008 | |||
| Mobility impairment | 0.19 | -0.30 to 0.68 | 0.436 | 0.13 | -0.35 to 0.61 | 0.600 | -0.07 | -0.39 to 0.53 | 0.770 | |||
| Cognition impairment | 0.44 | 0.16 to 0.73 | 0.003 | 0.37 | 0.09 to 0.66 | 0.011 | 0.33 | 0.05 to 0.60 | 0.020 | |||
| Signs of depression | -0.01 | -0.38 to 0.36 | 0.958 | -0.08 | -0.45 to 0.28 | 0.657 | -0.14 | -0.49 to 0.20 | 0.414 | |||
β, standardized regression coefficient; B, unstandardized regression coefficient; CI, confidence interval; other abbreviations as in Table 1.
Predictors of total hours of physiotherapy for patients with ISAR+ receiving CGA (n = 300).
| Unadjusted | Model 1 | Model 2 | Model 3 | |||||||||
| β or B | 95% CI | p-value | β or B | 95% CI | p-value | β or B | 95% CI | p-value | β or B | 95% CI | p-value | |
| Age | -0.13 | -0.26 to -0.01 | 0.035 | -0.12 | -0.25 to 0.01 | 0.080 | -0.18 | -0.30 to -0.05 | 0.007 | -0.17 | -0.30 to -0.04 | 0.009 |
| Sex (male vs female) | 0.25 | -0.50 to 1.01 | 0.512 | 0.08 | -0.69 to 0.85 | 0.840 | 0.02 | -0.74 to 0.78 | 0.958 | 0.06 | -0.70 to 0.82 | 0.877 |
| Number of admission diagnoses | 0.20 | 0.08 to 0.32 | 0.001 | |||||||||
| ISAR score | -0.08 | -0.20 to 0.04 | 0.185 | -0.05 | -0.18 to 0.08 | 0.437 | ||||||
| Activities of daily living impairment (yes vs no) | 1.54 | 0.56 to 2.52 | 0.002 | 1.79 | 0.80 to 2.78 | <0.001 | ||||||
| Mobility impairment | 1.36 | 0.43 to 2.28 | 0.004 | 1.66 | 0.71 to 2.62 | 0.001 | ||||||
| Cognition impairment | -0.12 | -0.81 to 0.57 | 0.733 | -0.21 | -0.90 to 0.49 | 0.554 | -0.18 | -0.87 to 0.51 | 0.605 | |||
| Signs of depression | 0.31 | -0.59 to 1.21 | 0.493 | 0.21 | -0.68 to 1.11 | 0.641 | 0.33 | -0.56 to 1.22 | 0.465 | |||
| Model 4 | Model 5 | Model 6 | ||||||||||
| β or B | 95% CI | p-value | β or B | 95% CI | p-value | β or B | 95% CI | p-value | ||||
| Age | -0.18 | -0.31 to -0.05 | 0.006 | -0.16 | -0.29 to -0.03 | 0.014 | -0.16 | -0.28 to -0.03 | 0.018 | |||
| Sex (male vs female) | 0.04 | -0.71 to 0.79 | 0.917 | 0.01 | -0.75 to 0.77 | 0.980 | -0.24 | -1.02 to 0.53 | 0.536 | |||
| Number of admission diagnoses | 0.16 | 0.04 to 0.29 | 0.012 | |||||||||
| ISAR score | -0.08 | -0.20 to 0.05 | 0.241 | -0.08 | -0.21 to 0.04 | 0.196 | ||||||
| Activities of daily living impairment (yes vs no) | 1.16 | -0.16 to 2.47 | 0.084 | 1.19 | -0.12 to 2.50 | 0.075 | 1.00 | -0.31 to 2.30 | 0.134 | |||
| Mobility impairment | 0.93 | -0.33 to 2.19 | 0.147 | 0.95 | -0.31 to 2.21 | 0.138 | 0.88 | -0.37 to 2.12 | 0.169 | |||
| Cognition impairment | -0.22 | -0.91 to 0.47 | 0.532 | -0.17 | -0.87 to 0.53 | 0.632 | -0.23 | -0.92 to 0.47 | 0.522 | |||
| Signs of depression | 0.26 | -0.64 to 1.15 | 0.572 | 0.32 | -0.58 to 1.22 | 0.490 | 0.21 | -0.68 to 1.10 | 0.642 | |||
β, standardized regression coefficient; B, unstandardized regression coefficient; CI, confidence interval; other abbreviations as in Table 1.